The PROSPECT Is Bright for CFTR Modulators

Ann Am Thorac Soc. 2021 Jan;18(1):32-33. doi: 10.1513/AnnalsATS.202007-881ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aminophenols
  • Aminopyridines
  • Benzodioxoles
  • Cystic Fibrosis Transmembrane Conductance Regulator* / genetics
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / genetics
  • Humans
  • Quinolones
  • Treatment Outcome

Substances

  • Aminophenols
  • Aminopyridines
  • Benzodioxoles
  • Quinolones
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • ivacaftor
  • lumacaftor